• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

程序性死亡受体1(PD-1)基因多态性变异与复发缓解型多发性硬化症的首发症状及疾病严重程度相关。

PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS.

作者信息

Pawlak-Adamska Edyta, Nowak Oskar, Karabon Lidia, Pokryszko-Dragan Anna, Partyka Anna, Tomkiewicz Anna, Ptaszkowski Jakub, Frydecka Irena, Podemski Ryszard, Dybko Jaroslaw, Bilinska Malgorzata

机构信息

Department of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigl 12, 53-114 Wroclaw, Poland.

Department of Human Evolutionary Biology, Institute of Anthropology, Adam Mickiewicz University, Umultowska 89, 61-614 Poznan, Poland.

出版信息

J Neuroimmunol. 2017 Apr 15;305:115-127. doi: 10.1016/j.jneuroim.2017.02.006. Epub 2017 Feb 9.

DOI:10.1016/j.jneuroim.2017.02.006
PMID:28284331
Abstract

Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS), where inflammation, demyelination together with the axonopathy are the cardinal features on pathologic ground, with a combined genetic and environmental background. The associations of PD-1 single nucleotide polymorphisms (SNPs): PD-1.3 (in intron 4), PD-1.5 and PD-1.9 (both in exon 5) with clinical manifestation of MS in 479 south Polish individuals including 203 MS patients were analyzed. Presence of PD-1.5T allele was linked with the first manifestations of disease: diplopia and pyramidal signs - favored pyramidal signs but protected against of diplopia development. Farther, PD-1.3G/PD-1.5C/PD-1.9C haplotype significantly favored whereas GTC protected against diplopia. Besides, GTT haplotype strongly favored non-severe RRMS outcome and ATC haplotype was specific only for these MS patients. Our population-based case-control study, investigating selected three PD-1 SNPs: PD-1.3, PD-1.5 and PD-1.9, revealed that polymorphic variation may be rather disease-modifying than MS risk factor.

摘要

多发性硬化症(MS)是一种中枢神经系统(CNS)的炎症性疾病,炎症、脱髓鞘以及轴索性病变是其病理基础的主要特征,具有遗传和环境双重背景。对479名波兰南部个体(包括203名MS患者)中PD-1单核苷酸多态性(SNP):PD-1.3(位于内含子4)、PD-1.5和PD-1.9(均位于外显子5)与MS临床表现的相关性进行了分析。PD-1.5T等位基因的存在与疾病的首发表现相关:复视和锥体束征——更易出现锥体束征,但可预防复视的发生。此外,PD-1.3G/PD-1.5C/PD-1.9C单倍型显著增加复视风险,而GTC单倍型则可预防复视。此外,GTT单倍型强烈增加非严重复发缓解型多发性硬化症(RRMS)的发病风险,而ATC单倍型仅在这些MS患者中出现。我们基于人群的病例对照研究,调查了选定的三个PD-1 SNP:PD-1.3、PD-1.5和PD-1.9,结果显示多态性变异可能更多是疾病修饰因素而非MS的危险因素。

相似文献

1
PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS.程序性死亡受体1(PD-1)基因多态性变异与复发缓解型多发性硬化症的首发症状及疾病严重程度相关。
J Neuroimmunol. 2017 Apr 15;305:115-127. doi: 10.1016/j.jneuroim.2017.02.006. Epub 2017 Feb 9.
2
Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.遗传易感性变异在多发性硬化症临床病程预测中的作用:一项队列研究。
J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1204-1211. doi: 10.1136/jnnp-2016-313722. Epub 2016 Aug 24.
3
OAS1: a multiple sclerosis susceptibility gene that influences disease severity.OAS1:多发性硬化症易感性基因,影响疾病严重程度。
Neurology. 2010 Aug 3;75(5):411-8. doi: 10.1212/WNL.0b013e3181ebdd2b.
4
IL12B gene polymorphisms have sex-specific effects in relapsing-remitting multiple sclerosis.白细胞介素12B基因多态性在复发缓解型多发性硬化症中具有性别特异性效应。
Acta Neurol Belg. 2019 Mar;119(1):83-93. doi: 10.1007/s13760-018-01066-3. Epub 2018 Dec 15.
5
Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis.ADAMTS14基因多态性与多发性硬化症之间的遗传关联。
J Neuroimmunol. 2005 Jul;164(1-2):140-7. doi: 10.1016/j.jneuroim.2005.04.005.
6
Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.CASP8 多态性与原发进展型多发性硬化的遗传关联。
J Neuroimmunol. 2010 May;222(1-2):70-5. doi: 10.1016/j.jneuroim.2010.03.003. Epub 2010 Apr 2.
7
Single nucleotide polymorphisms in the FOXP3 gene are associated with increased risk of relapsing-remitting multiple sclerosis.FOXP3基因中的单核苷酸多态性与复发缓解型多发性硬化症风险增加相关。
Hum Antibodies. 2016;24(3-4):85-90. doi: 10.3233/HAB-160299.
8
Analysis of MMP2-1306C/T and TIMP2G-418C polymorphisms with relapsing remitting multiple sclerosis.MMP2 - 1306C/T和TIMP2G - 418C基因多态性与复发缓解型多发性硬化症的分析
J Investig Med. 2016 Aug;64(6):1143-7. doi: 10.1136/jim-2016-000111. Epub 2016 May 12.
9
NOS2A as a candidate gene in Relapsing-Remitting Multiple Sclerosis: a haplotype study using selected subsets of single nucleotide polymorphisms.NOS2A 作为复发性多发性硬化症的候选基因:使用单核苷酸多态性的选定子集进行单体型研究。
J Neurol Sci. 2011 May 15;304(1-2):75-7. doi: 10.1016/j.jns.2011.02.008. Epub 2011 Mar 3.
10
Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study.维生素D受体(VDR)基因多态性在多发性硬化症发病中的易感作用:一项病例对照研究。
J Neurol Sci. 2016 Aug 15;367:148-51. doi: 10.1016/j.jns.2016.05.053. Epub 2016 Jun 1.

引用本文的文献

1
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice.免疫检查点为基础的免疫疗法在多发性硬化中的进展:原理与实践。
Cell Commun Signal. 2023 Nov 9;21(1):321. doi: 10.1186/s12964-023-01289-9.
2
Regulation of the programmed cell death protein 1/programmed cell death ligand 1 axis in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化中程序性细胞死亡蛋白1/程序性细胞死亡配体1轴的调控
Brain Commun. 2023 Jul 25;5(4):fcad206. doi: 10.1093/braincomms/fcad206. eCollection 2023.
3
Autoimmunity and Carcinogenesis: Their Relationship under the Umbrella of Autophagy.
自身免疫与癌症发生:自噬框架下它们的关系
Biomedicines. 2023 Apr 8;11(4):1130. doi: 10.3390/biomedicines11041130.
4
T follicular helper cells and T follicular regulatory cells in autoimmune diseases.自身免疫性疾病中的滤泡辅助 T 细胞和滤泡调节 T 细胞。
Front Immunol. 2023 Apr 28;14:1178792. doi: 10.3389/fimmu.2023.1178792. eCollection 2023.
5
PD-1/PD-L Axis in Neuroinflammation: New Insights.神经炎症中的PD-1/PD-L轴:新见解
Front Neurol. 2022 Jun 9;13:877936. doi: 10.3389/fneur.2022.877936. eCollection 2022.
6
Autoimmunity and Cancer-Two Sides of the Same Coin.自身免疫与癌症——一枚硬币的两面。
Front Immunol. 2022 May 13;13:793234. doi: 10.3389/fimmu.2022.793234. eCollection 2022.
7
Association of PD-1 and PDL-1 gene polymorphisms with colorectal cancer risk and prognosis.PD-1和PDL-1基因多态性与结直肠癌风险及预后的关联
Mol Biol Rep. 2022 Mar;49(3):1827-1836. doi: 10.1007/s11033-021-06992-9. Epub 2022 Jan 25.
8
PD-1/PD-L1 Axis as a Potential Therapeutic Target for Multiple Sclerosis: A T Cell Perspective.PD-1/PD-L1轴作为多发性硬化症的潜在治疗靶点:T细胞视角
Front Cell Neurosci. 2021 Jul 26;15:716747. doi: 10.3389/fncel.2021.716747. eCollection 2021.
9
Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis.西尼莫德可使继发进展型多发性硬化症患者体内的调节性T淋巴细胞和B淋巴细胞增多。
JCI Insight. 2020 Feb 13;5(3):134251. doi: 10.1172/jci.insight.134251.
10
Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.多发性硬化症患者的遗传与分子生物学:综述。
Cell Mol Neurobiol. 2020 Jan;40(1):65-85. doi: 10.1007/s10571-019-00731-2. Epub 2019 Sep 3.